STOCK TITAN

Kamada CEO London Amir awarded 800,000 stock options

The awards vest over four grant anniversaries, and their exercise prices were adjusted in connection with a special cash dividend.

(Neutral)
(Neutral)
Form Type
4

Rhea-AI Filing Summary

KAMADA LTD (KMDA) reports two employee stock-option awards for London Amir, Chief Executive Officer, each covering 400,000 ordinary shares and dated August 27, 2026. The options are held by a trustee under the company's 2011 Share Award Plan, with exercise prices of $5.99 and $7.44 per share. They vest in four equal installments, with 25% vesting on each anniversary of the grant date. The exercise prices were adjusted in connection with the special cash dividend declared by the board on August 17, 2026. Prices are presented in U.S. dollars based on the Bank of Israel NIS/USD exchange rate as of September 22, 2026.

Positive

  • None.

Negative

  • None.
Insider London Amir
Role Chief Executive Officer
Type Security Shares Price Value
Grant/Award Employee Stock Option (right to buy) F1, F4, F2, F3 400,000 $0.00 $0.00
Grant/Award Employee Stock Option (right to buy) F1, F5, F2, F3 400,000 $0.00 $0.00
Holdings After Transaction: Employee Stock Option (right to buy) — 800,000 contracts (Indirect, Held by trustee)
Footnotes (5)
  1. F1. The exercise prices of all options reported in this Form 4 are denominated in New Israeli Shekels (NIS). For presentation purposes, all exercise prices presented in this Form 4, including those referenced in the footnotes, are presented in U.S. dollars (USD) based on the NIS/USD exchange rate published by the Bank of Israel as of September 22, 2026.
  2. F2. Options vest in four equal installments, with 25% vesting on each of the four anniversaries of the date of grant.
  3. F3. Held by trustee under the Company's 2011 Share Award Plan.
  4. F4. This option was previously reported as covering 400,000 ordinary shares at an exercise price of $6.15. The exercise price has been adjusted in connection with a special cash dividend distribution declared by the Company's board of directors on August 17, 2026 with a record date for the special cash dividend of August 27, 2026.
  5. F5. This option was previously reported as covering 400,000 ordinary shares at an exercise price of $7.61. The exercise price has been adjusted in connection with a special cash dividend distribution declared by the Company's board of directors on August 17, 2026 with a record date for the special cash dividend of August 27, 2026.
Options awarded at $5.99 exercise price 400,000 options Each covers 400,000 ordinary shares; dated August 27, 2026.
Exercise price $5.99 per share Option award covering 400,000 ordinary shares.
Options awarded at $7.44 exercise price 400,000 options Each covers 400,000 ordinary shares; dated August 27, 2026.
Exercise price $7.44 per share Option award covering 400,000 ordinary shares.
Vesting installments 4 installments Options vest in equal installments on the four anniversaries of the grant date.
Vesting per installment 25% Of the options, vesting on each anniversary of the grant date.
Employee Stock Option (right to buy) technical
"Employee Stock Option (right to buy)"
exercise price financial
"The exercise price has been adjusted in connection with a special cash dividend distribution"
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
vest technical
"Options vest in four equal installments"
A vest is the process by which an employee earns the right to receive certain benefits or ownership interests, such as stock or retirement funds, over time. It’s similar to earning a reward gradually, ensuring that the benefit becomes fully yours only after a set period or meeting specific conditions. This makes it important for investors because it determines when they can actually claim or use those benefits.
2011 Share Award Plan technical
"Held by trustee under the Company's 2011 Share Award Plan"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many KMDA options were awarded to the CEO, and what are their exercise prices?

KAMADA LTD reported two employee stock-option awards for Chief Executive Officer London Amir, each covering 400,000 ordinary shares. The options are held by a trustee under the 2011 Share Award Plan, with exercise prices of $5.99 and $7.44 per share.

How do the KMDA options vest?

The options vest in four equal installments, with 25% vesting on each of the four anniversaries of the grant date.

Why were the KMDA option exercise prices adjusted?

The prices were adjusted in connection with a special cash dividend distribution declared by the board on August 17, 2026, with a record date of August 27, 2026. The options had previously been reported with exercise prices of $6.15 and $7.61, respectively.

Were the KMDA option awards reported under a Rule 10b5-1 plan?

No Rule 10b5-1 plan is reported for these option awards.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
London Amir

(Last)(First)(Middle)
2 HOLTZMAN ST.

(Street)
REHOVOT

(City)(State)(Zip)

ISRAEL

(Country)
2. Issuer Name and Ticker or Trading Symbol
KAMADA LTD [ KMDA ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director10% Owner
XOfficer (give title below)Other (specify below)
Chief Executive Officer
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
08/27/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Employee Stock Option (right to buy)$5.99(1)(4)08/27/2026A400,000 (2) (2)Ordinary Shares400,000$0.00400,000IHeld by trustee(3)
Employee Stock Option (right to buy)$7.44(1)(5)08/27/2026A400,000 (2) (2)Ordinary Shares400,000$0.00400,000IHeld by trustee(3)
Explanation of Responses:
1. The exercise prices of all options reported in this Form 4 are denominated in New Israeli Shekels (NIS). For presentation purposes, all exercise prices presented in this Form 4, including those referenced in the footnotes, are presented in U.S. dollars (USD) based on the NIS/USD exchange rate published by the Bank of Israel as of September 22, 2026.
2. Options vest in four equal installments, with 25% vesting on each of the four anniversaries of the date of grant.
3. Held by trustee under the Company's 2011 Share Award Plan.
4. This option was previously reported as covering 400,000 ordinary shares at an exercise price of $6.15. The exercise price has been adjusted in connection with a special cash dividend distribution declared by the Company's board of directors on August 17, 2026 with a record date for the special cash dividend of August 27, 2026.
5. This option was previously reported as covering 400,000 ordinary shares at an exercise price of $7.61. The exercise price has been adjusted in connection with a special cash dividend distribution declared by the Company's board of directors on August 17, 2026 with a record date for the special cash dividend of August 27, 2026.
/s/ Amir London09/25/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Keep reading